ASML vs PMCB · P/E 57, $665.37B cap vs $8.6M cap
ASML Holding NV ADR (ASML) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the ASML and PMCB stock pages for the full models.
Not investment advice.